-
ALDH2, Cardiomyocyte Proliferation, and Heart Failure
2026-10-01
The reference study identifies ALDH2 as more than a mitochondrial aldehyde-detoxifying enzyme: its activation also extends the proliferative window of cardiomyocytes and delays pressure overload-induced heart failure in mice. By combining neonatal cardiomyocyte experiments with an adult transverse aortic constriction model, the work connects aldehyde handling to cardiac regeneration and provides a framework for future ALDH2-targeted studies.
-
STING Activation by PI4P and GNE-6468
2026-10-01
The reference study defines how the Golgi lipid PI4P cooperates with the chemical agonist GNE-6468 to activate STING through transmembrane-helix rearrangement rather than ligand-binding-domain remodeling. Cryo-EM and functional analyses connect this structural mechanism with STING oligomerization, antiviral signaling, and antitumor immunity, providing a framework for mechanism-guided immunotherapy research.
-
Gallein: G Protein βγ Inhibitor Workflows
2026-09-30
Gallein is a practical pharmacological probe for testing whether GPCR outputs depend on G protein βγ signaling across cancer, immunology, cardiac inflammation, and metabolism. This guide translates product-backed benchmark models into reproducible assay workflows while separating established evidence from exploratory applications inspired by lactate–GPR81 research.
-
Ionomycin Calcium Salt: Assay Workflow Guide
2026-09-30
Build reproducible calcium-perturbation assays with Ionomycin calcium salt, from intracellular Ca2+ flux and secretion studies to exploratory cancer-cell fate experiments. This guide connects practical ionophore workflows with the JNK-USP36-Snail1 ribotoxic-stress model while separating established evidence from hypothesis-driven extensions.
-
Golgi-Tracker Green for Live-Cell Imaging
2026-09-29
Golgi-Tracker Green enables selective, photostable visualization of Golgi membranes in living cells while supporting lipid-trafficking and sphingolipid studies. This practical guide covers assay setup, quantitative imaging, troubleshooting, and how to interpret Golgi remodeling alongside cancer-mechanism data.
-
Circular RNA CAR-T Therapy for Small Cell Lung Cancer
2026-09-29
Cai and colleagues developed a transient DLL3-targeted CAR-T approach by electroporating human primary T cells with circular RNA rather than using a viral vector. In the reported models, circRNA-based CAR-T cells outperformed mRNA-based cells and eliminated tumors in both subcutaneous and orthotopic small cell lung cancer models, while important translational questions remain regarding manufacturing, durability, and clinical safety.
-
Hematoxylin and Eosin Staining Kit: Practical Use
2026-09-28
The Hematoxylin and Eosin staining kit (SKU K1142) provides ready-to-use reagents for visualizing nuclei, cytoplasm, and tissue architecture in histological and cytological preparations. It supports research assessment of morphology, but it is not a diagnostic test and does not replace assays for molecular identity, cell function, or disease classification.
-
Palonosetron: Pharmacology, PK, and CINV Evidence
2026-09-27
The 2010 review of palonosetron hydrochloride brings together receptor-binding, animal, pharmacokinetic, and clinical evidence for a selective 5-HT3 receptor antagonist with a long elimination half-life. In a Japanese comparison with granisetron, palonosetron was noninferior for acute chemotherapy-induced nausea and vomiting and superior for delayed symptoms, supporting its role in chemotherapy supportive care while leaving important mechanistic and population-specific questions open.
-
QX77: Molecular Chaperone Activator Workflows
2026-09-26
QX77 offers a practical way to test LAMP2A- and Rab11-linked changes in chaperone-mediated autophagy, while its reported effects on embryonic stem-cell self-renewal open a distinct stem cell biology use-case. These workflows treat QX77 as an experimental probe—not as a stand-in for mitophagy inhibition or evidence of therapeutic benefit.
-
IAM LC vs LEKC in Pulmonary Drug Permeability
2026-09-26
A 2024 comparison of immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) tested how well each biomimetic method reflects drug partitioning and apparent lung permeability. LEKC showed the stronger relationship with pulmonary permeability, while IAM LC offered broader compound coverage and practical advantages for screening.
-
Thapsigargin for Calcium Signaling and ER Stress
2026-09-25
Use Thapsigargin to impose a rapid, mechanistically defined SERCA block and connect calcium imaging with downstream ER-stress and cell-fate readouts. This workflow emphasizes timing, cell-specific dose finding, and the distinction between a broad stress inducer and a pathway-selective screening hit.
-
Doxycycline Hyclate: Testing MMP Causality
2026-09-25
Explore how Doxycycline hyclate can help test whether matrix metalloproteinase activity contributes to vascular barrier injury. This article turns evidence from an arsenite mouse study into a practical framework for distinguishing an MMP-linked mechanism from a broad drug-response effect.
-
Reversine (A3760): Practical Aurora Kinase Workflow
2026-09-24
Reversine (A3760) is an Aurora kinase inhibitor for investigating mitotic regulation and related cancer-cell phenotypes, including proliferation and apoptosis. Use it in controlled research assays—not for diagnostic or medical purposes—and treat the product’s biochemical IC₅₀ values as context rather than as cell-culture dosing instructions.
-
Resazurin Sodium Salt for Metabolic Stress Assays
2026-09-24
Resazurin sodium salt reports cellular reducing activity, not cell number or hormone function directly. Learn how to use this fluorogenic oxidation-reduction indicator to interpret metabolic stress assays alongside evidence on microbiota-derived hydrogen sulfide and GLP-1.
-
DiscoveryProbe Natural Product Library Plus for HTS
2026-09-23
DiscoveryProbe Natural Product Library Plus enables a decision-oriented natural product library workflow that connects biochemical screening with cell-based validation. Using CpAdhE research as a model, this article explains how to prioritize hits, control assay artifacts, and assess translational relevance.